Endpoint Preclinical is excited to announce our participation in the 2024 Safety Pharmacology Society (SPS) Annual Meeting, happening from September 22–25, 2024, at the Town and Country San Diego. This event brings together top scientists, researchers, and industry leaders from around the globe to discuss groundbreaking advancements in safety pharmacology, regulatory practices, and innovative research methodologies.

If you’re attending, don’t miss the chance to connect with our team and explore how we’re advancing preclinical research to improve drug safety and efficacy.

Why Attend SPS 2024: The Safety Pharmacology Society Annual Meeting is the premier event for staying up to date on cutting-edge research and industry trends. Here’s why it matters:

• Access to Leading Research: Dive into the latest discoveries and advancements that are shaping the future of safety pharmacology.
• Regulatory Insights: Understand how evolving guidelines and methodologies can improve drug development and safety testing.
• Career Development: Whether you’re an experienced professional or just starting out, SPS provides a unique platform for knowledge sharing and collaboration.

Endpoint Preclinical is looking forward to engaging with attendees at SPS 2024. Here’s how you can connect with us:

• LinkedIn: Connect with Cole McLarty and Andy Henton via LinkedIn to communicate before and while at the meeting.
• Event App: Download the SPS2024 Event App and connect with us in the Attendee portal.
• Schedule a Meeting: Send us an email and we can arrange a time to meet on-site during the conference.